Literature DB >> 22365251

Interstitial lung disease in the connective tissue diseases.

Danielle Antin-Ozerkis1, Ami Rubinowitz, Janine Evans, Robert J Homer, Richard A Matthay.   

Abstract

The connective tissue diseases (CTDs) are inflammatory, immune-mediated disorders in which interstitial lung disease (ILD) is common and clinically important. Interstitial lung disease may be the first manifestation of a CTD in a previously healthy patient. CTD-associated ILD frequently presents with the gradual onset of cough and dyspnea, although rarely may present with fulminant respiratory failure. Infection and drug reaction should always be ruled out. A diagnosis of idiopathic ILD should never be made without a careful search for subtle evidence of underlying CTD. Treatment of CTD-ILD typically includes corticosteroids and immunosuppressive agents. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365251     DOI: 10.1016/j.ccm.2012.01.004

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  7 in total

1.  Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists.

Authors:  Sarah Geerts; Wim Wuyts; Ellen De Langhe; Jan Lenaerts; Jonas Yserbyt
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

2.  Dramatic improvement of anti-SS-A/Ro-associated interstitial lung disease after immunosuppressive treatment.

Authors:  Caramaschi Paola; Festi Giuliana; Orsolini Giovanni; Caimmi Cristian; Biasi Domenico
Journal:  Rheumatol Int       Date:  2016-03-28       Impact factor: 2.631

Review 3.  Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease.

Authors:  So My Koo; Song Yee Kim; Sun Mi Choi; Hyun Kyung Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2019-05-31

4.  Pirfenidone inhibits cell fibrosis in connective tissue disease-associated interstitial lung disease by targeting the TNF-α/STAT3/KL6 pathway.

Authors:  Yanhua Zuo; Jing Liu; Huaheng Xu; Yanxia Li; Ran Tao; Zongfang Zhang
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

5.  Temporal Trends in Characteristics of Newly Diagnosed Nontraumatic Osteonecrosis of the Femoral Head From 1997 to 2011: A Hospital-Based Sentinel Monitoring System in Japan.

Authors:  Shinji Takahashi; Wakaba Fukushima; Takuaki Yamamoto; Yukihide Iwamoto; Toshikazu Kubo; Nobuhiko Sugano; Yoshio Hirota
Journal:  J Epidemiol       Date:  2015-04-25       Impact factor: 3.211

Review 6.  Interpretation of autoantibody positivity in interstitial lung disease and lung-dominant connective tissue disease.

Authors:  Daniel Antunes Silva Pereira; Alexandre de Melo Kawassaki; Bruno Guedes Baldi
Journal:  J Bras Pneumol       Date:  2013 Nov-Dec       Impact factor: 2.624

7.  Serum levels of Krebs von den Lungen-6 as a promising marker for predicting occurrence and deterioration of systemic sclerosis-associated interstitial lung disease from a Chinese cohort.

Authors:  Xiao-Yu Cao; Sha-Sha Hu; Dong Xu; Meng-Tao Li; Qian Wang; Yong Hou; Xiao-Feng Zeng
Journal:  Int J Rheum Dis       Date:  2018-12-28       Impact factor: 2.454

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.